Core Points - The articles outline the articles of association for Sailong Pharmaceutical Group Co., Ltd, detailing the company's legal framework, governance structure, and operational guidelines [1][2][3]. Group 1: Company Overview - Sailong Pharmaceutical Group Co., Ltd is established as a joint-stock company in accordance with the Company Law and other relevant regulations [1]. - The registered capital of the company is RMB 176.6 million [2]. - The company is located at 31 Nanwan North Road, Xiangzhou District, Zhuhai, Guangdong Province, with a postal code of 519060 [1]. Group 2: Governance Structure - The legal representative of the company is elected by the board of directors and must be a director or the general manager [2]. - The company’s assets are divided into equal shares, and shareholders are liable for the company's debts only to the extent of their subscribed shares [2][3]. - The articles of association serve as a legally binding document for the company, shareholders, directors, and senior management [2]. Group 3: Business Objectives and Scope - The company's business objective is to enhance management levels and core competitiveness while providing quality services to customers and maximizing shareholder value [3]. - The business scope includes drug production, wholesale, food production, medical devices, and related services, subject to legal approvals [3][4]. Group 4: Share Issuance and Management - The company issues shares in the form of stocks, with each share having a par value of RMB 1 [5][6]. - The total number of shares issued by the company is 176 million, all of which are ordinary shares [5]. - The company cannot provide financial assistance for the purchase of its shares in any form [5]. Group 5: Shareholder Rights and Responsibilities - Shareholders have the right to receive dividends, attend meetings, supervise company operations, and transfer their shares [9][10]. - Shareholders must comply with laws and the articles of association, and they are liable for any damages caused by the abuse of their rights [13][39]. - The company must maintain transparency and provide necessary information to shareholders regarding their rights and the company's operations [10][12]. Group 6: Shareholder Meetings - The company holds annual and temporary shareholder meetings, with specific procedures for calling and conducting these meetings [18][19]. - Shareholder proposals must be submitted in writing and can be made by shareholders holding at least 1% of the shares [23][24]. - Decisions at shareholder meetings require a majority or supermajority vote, depending on the nature of the resolution [78][80].
*ST赛隆: 公司章程(2025年8月)